September 27, 2022 07:18 AM EDT
Pharma
Law

Bio­gen pays $900M to set­tle wide-rang­ing physi­cian kick­back claims

Zachary Brennan

Senior Editor

Look­ing to clear the deck ahead of its long-await­ed lecanemab da­ta re­lease, Bio­gen agreed to pay the US gov­ern­ment and states a whop­ping $900 mil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J part­ners on STAT6; As­traZeneca, Dai­ichi with­draw lung can­cer drug EMA app

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

A service from the Financial Times